Rapid advances in artificial intelligence (AI) and availability of biological, medical, and healthcare data have enabled the development of a wide variety of models. Significant success has been achieved in a wide range of fields, such as genomics, protein folding, disease diagnosis, imaging, and clinical tasks. Although widely used, the inherent opacity of deep AI models has brought criticism from the research field and little adoption in clinical practice. Concurrently, there has been a significant amount of research focused on making such methods more interpretable, reviewed here, but inherent critiques of such explainability in AI (XAI), its requirements, and concerns with fairness/robustness have hampered their real-world adoption. We here discuss how user-driven XAI can be made more useful for different healthcare stakeholders through the definition of three key personas-data scientists, clinical researchers, and clinicians-and present an overview of how different XAI approaches can address their needs. For illustration, we also walk through several research and clinical examples that take advantage of XAI open-source tools, including those that help enhance the explanation of the results through visualization. This perspective thus aims to provide a guidance tool for developing explainability solutions for healthcare by empowering both subject matter experts, providing them with a survey of available tools, and explainability developers, by providing examples of how such methods can influence in practice adoption of solutions.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122967 | PMC |
http://dx.doi.org/10.1016/j.patter.2022.100493 | DOI Listing |
Arch Bronconeumol
November 2024
Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, 50139 Florence, Italy. Electronic address:
In this narrative review, we address the ongoing challenges of lung cancer (LC) screening using chest low-dose computerized tomography (LDCT) and explore the contributions of artificial intelligence (AI), in overcoming them. We focus on evaluating the initial (baseline) LDCT examination, which provides a wealth of information relevant to the screening participant's health. This includes the detection of large-size prevalent LC and small-size malignant nodules that are typically diagnosed as LCs upon growth in subsequent annual LDCT scans.
View Article and Find Full Text PDFFront Artif Intell
October 2024
HU University of Applied Sciences Utrecht, Research Group Artificial Intelligence, Utrecht, Netherlands.
Explainable Artificial Intelligence (XAI) aims to provide insights into the inner workings and the outputs of AI systems. Recently, there's been growing recognition that explainability is inherently human-centric, tied to how people perceive explanations. Despite this, there is no consensus in the research community on whether user evaluation is crucial in XAI, and if so, what exactly needs to be evaluated and how.
View Article and Find Full Text PDFPLoS One
October 2024
Sandwell And West Birmingham Hospitals NHS Trust, Birmingham, United Kingdom.
Internet Interv
December 2024
Digital Health Research, Center for Digital Health and Wellbeing, Fondazione Bruno Kessler, Trento, Italy.
Background: AI-powered Digital Therapeutics (DTx) hold potential for enhancing stress prevention by promoting the scalability of P5 Medicine, which may offer users coping skills and improved self-management of mental wellbeing. However, adoption rates remain low, often due to insufficient user and stakeholder involvement during the design phases.
Objective: This study explores the human-centered design potentials of SHIVA, a DTx integrating virtual reality and AI with the SelfHelp+ intervention, aiming to understand stakeholder views and expectations that could influence its adoption.
Comput Med Imaging Graph
October 2024
Department Di.Chir.On.S, University of Palermo, Palermo, Italy; Unit of Oral Medicine and Dentistry for fragile patients, Department of Rehabilitation, fragility, and continuity of care University Hospital Palermo, Palermo, Italy.
Oral squamous cell carcinoma recognition presents a challenge due to late diagnosis and costly data acquisition. A cost-efficient, computerized screening system is crucial for early disease detection, minimizing the need for expert intervention and expensive analysis. Besides, transparency is essential to align these systems with critical sector applications.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!